nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyridostigmine—CYP3A4—Thiotepa—sarcoma	0.319	0.458	CbGbCtD
Pyridostigmine—CYP3A4—Mitoxantrone—sarcoma	0.137	0.197	CbGbCtD
Pyridostigmine—CYP3A4—Vincristine—sarcoma	0.0944	0.136	CbGbCtD
Pyridostigmine—CYP3A4—Etoposide—sarcoma	0.0865	0.124	CbGbCtD
Pyridostigmine—CYP3A4—Doxorubicin—sarcoma	0.059	0.0848	CbGbCtD
Pyridostigmine—Abdominal cramps—Vincristine—sarcoma	0.00757	0.0249	CcSEcCtD
Pyridostigmine—Pulmonary oedema—Thiotepa—sarcoma	0.00513	0.0169	CcSEcCtD
Pyridostigmine—Chest discomfort—Etoposide—sarcoma	0.00468	0.0154	CcSEcCtD
Pyridostigmine—Lethargy—Dactinomycin—sarcoma	0.00424	0.0139	CcSEcCtD
Pyridostigmine—Cardiac arrest—Thiotepa—sarcoma	0.00398	0.0131	CcSEcCtD
Pyridostigmine—Lacrimation—Epirubicin—sarcoma	0.00395	0.013	CcSEcCtD
Pyridostigmine—Lacrimation—Doxorubicin—sarcoma	0.00365	0.012	CcSEcCtD
Pyridostigmine—Cardiac arrest—Vincristine—sarcoma	0.00353	0.0116	CcSEcCtD
Pyridostigmine—Sweating increased—Mitoxantrone—sarcoma	0.00304	0.01	CcSEcCtD
Pyridostigmine—Epistaxis—Thiotepa—sarcoma	0.00304	0.01	CcSEcCtD
Pyridostigmine—Amblyopia—Epirubicin—sarcoma	0.00301	0.00988	CcSEcCtD
Pyridostigmine—Cardiac arrest—Etoposide—sarcoma	0.00286	0.00939	CcSEcCtD
Pyridostigmine—Drowsiness—Mitoxantrone—sarcoma	0.00278	0.00915	CcSEcCtD
Pyridostigmine—Amblyopia—Doxorubicin—sarcoma	0.00278	0.00914	CcSEcCtD
Pyridostigmine—Cramp muscle—Etoposide—sarcoma	0.00271	0.0089	CcSEcCtD
Pyridostigmine—Alopecia—Thiotepa—sarcoma	0.00256	0.00841	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Vincristine—sarcoma	0.00255	0.00839	CcSEcCtD
Pyridostigmine—Bradycardia—Mitoxantrone—sarcoma	0.00254	0.00836	CcSEcCtD
Pyridostigmine—Alopecia—Dactinomycin—sarcoma	0.00254	0.00834	CcSEcCtD
Pyridostigmine—Sweating increased—Etoposide—sarcoma	0.00253	0.00832	CcSEcCtD
Pyridostigmine—Lacrimation increased—Epirubicin—sarcoma	0.00252	0.00828	CcSEcCtD
Pyridostigmine—Neck pain—Epirubicin—sarcoma	0.00235	0.00772	CcSEcCtD
Pyridostigmine—Lacrimation increased—Doxorubicin—sarcoma	0.00233	0.00766	CcSEcCtD
Pyridostigmine—Agitation—Thiotepa—sarcoma	0.00232	0.00761	CcSEcCtD
Pyridostigmine—Alopecia—Vincristine—sarcoma	0.00227	0.00745	CcSEcCtD
Pyridostigmine—Salivary hypersecretion—Epirubicin—sarcoma	0.00225	0.00741	CcSEcCtD
Pyridostigmine—Alopecia—Mitoxantrone—sarcoma	0.00221	0.00726	CcSEcCtD
Pyridostigmine—Convulsion—Thiotepa—sarcoma	0.00218	0.00718	CcSEcCtD
Pyridostigmine—Neck pain—Doxorubicin—sarcoma	0.00217	0.00714	CcSEcCtD
Pyridostigmine—Myalgia—Thiotepa—sarcoma	0.00214	0.00705	CcSEcCtD
Pyridostigmine—Myalgia—Dactinomycin—sarcoma	0.00213	0.007	CcSEcCtD
Pyridostigmine—Salivary hypersecretion—Doxorubicin—sarcoma	0.00209	0.00685	CcSEcCtD
Pyridostigmine—Confusional state—Thiotepa—sarcoma	0.00207	0.00682	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Etoposide—sarcoma	0.00207	0.0068	CcSEcCtD
Pyridostigmine—Pulmonary oedema—Epirubicin—sarcoma	0.00207	0.00679	CcSEcCtD
Pyridostigmine—Agitation—Vincristine—sarcoma	0.00205	0.00675	CcSEcCtD
Pyridostigmine—Hypertonia—Epirubicin—sarcoma	0.00203	0.00669	CcSEcCtD
Pyridostigmine—Vertigo—Vincristine—sarcoma	0.00201	0.0066	CcSEcCtD
Pyridostigmine—Thrombophlebitis—Epirubicin—sarcoma	0.00195	0.0064	CcSEcCtD
Pyridostigmine—Convulsion—Vincristine—sarcoma	0.00194	0.00636	CcSEcCtD
Pyridostigmine—Pulmonary oedema—Doxorubicin—sarcoma	0.00191	0.00628	CcSEcCtD
Pyridostigmine—Myalgia—Vincristine—sarcoma	0.0019	0.00625	CcSEcCtD
Pyridostigmine—Convulsion—Mitoxantrone—sarcoma	0.00189	0.0062	CcSEcCtD
Pyridostigmine—Hypertonia—Doxorubicin—sarcoma	0.00188	0.00619	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00187	0.00616	CcSEcCtD
Pyridostigmine—Eye pain—Epirubicin—sarcoma	0.00187	0.00613	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00186	0.00611	CcSEcCtD
Pyridostigmine—Myalgia—Mitoxantrone—sarcoma	0.00185	0.00609	CcSEcCtD
Pyridostigmine—Paraesthesia—Thiotepa—sarcoma	0.00185	0.00607	CcSEcCtD
Pyridostigmine—Alopecia—Etoposide—sarcoma	0.00184	0.00604	CcSEcCtD
Pyridostigmine—Somnolence—Thiotepa—sarcoma	0.00183	0.00601	CcSEcCtD
Pyridostigmine—Thrombophlebitis—Doxorubicin—sarcoma	0.0018	0.00592	CcSEcCtD
Pyridostigmine—Confusional state—Mitoxantrone—sarcoma	0.00179	0.00589	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Vincristine—sarcoma	0.00176	0.00579	CcSEcCtD
Pyridostigmine—Muscle spasms—Etoposide—sarcoma	0.00174	0.00572	CcSEcCtD
Pyridostigmine—Eye pain—Doxorubicin—sarcoma	0.00173	0.00568	CcSEcCtD
Pyridostigmine—Lethargy—Epirubicin—sarcoma	0.00172	0.00565	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Mitoxantrone—sarcoma	0.00172	0.00564	CcSEcCtD
Pyridostigmine—Hypotension—Vincristine—sarcoma	0.0017	0.0056	CcSEcCtD
Pyridostigmine—Feeling abnormal—Thiotepa—sarcoma	0.00169	0.00557	CcSEcCtD
Pyridostigmine—Feeling abnormal—Dactinomycin—sarcoma	0.00168	0.00553	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Thiotepa—sarcoma	0.00168	0.00553	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Dactinomycin—sarcoma	0.00167	0.00549	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Vincristine—sarcoma	0.00166	0.00546	CcSEcCtD
Pyridostigmine—Hypotension—Mitoxantrone—sarcoma	0.00166	0.00545	CcSEcCtD
Pyridostigmine—Paraesthesia—Vincristine—sarcoma	0.00164	0.00538	CcSEcCtD
Pyridostigmine—Urticaria—Thiotepa—sarcoma	0.00163	0.00537	CcSEcCtD
Pyridostigmine—Vertigo—Etoposide—sarcoma	0.00163	0.00534	CcSEcCtD
Pyridostigmine—Abdominal pain—Thiotepa—sarcoma	0.00163	0.00534	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00162	0.00532	CcSEcCtD
Pyridostigmine—Abdominal pain—Dactinomycin—sarcoma	0.00161	0.0053	CcSEcCtD
Pyridostigmine—Cardiac arrest—Epirubicin—sarcoma	0.0016	0.00527	CcSEcCtD
Pyridostigmine—Paraesthesia—Mitoxantrone—sarcoma	0.00159	0.00524	CcSEcCtD
Pyridostigmine—Loss of consciousness—Etoposide—sarcoma	0.00159	0.00523	CcSEcCtD
Pyridostigmine—Lethargy—Doxorubicin—sarcoma	0.00159	0.00523	CcSEcCtD
Pyridostigmine—Somnolence—Mitoxantrone—sarcoma	0.00158	0.00519	CcSEcCtD
Pyridostigmine—Convulsion—Etoposide—sarcoma	0.00157	0.00515	CcSEcCtD
Pyridostigmine—Dry skin—Epirubicin—sarcoma	0.00154	0.00508	CcSEcCtD
Pyridostigmine—Hypersensitivity—Thiotepa—sarcoma	0.00151	0.00498	CcSEcCtD
Pyridostigmine—Hypersensitivity—Dactinomycin—sarcoma	0.0015	0.00494	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Vincristine—sarcoma	0.00149	0.0049	CcSEcCtD
Pyridostigmine—Confusional state—Etoposide—sarcoma	0.00149	0.0049	CcSEcCtD
Pyridostigmine—Cardiac arrest—Doxorubicin—sarcoma	0.00148	0.00487	CcSEcCtD
Pyridostigmine—Asthenia—Thiotepa—sarcoma	0.00148	0.00485	CcSEcCtD
Pyridostigmine—Abdominal distension—Epirubicin—sarcoma	0.00147	0.00482	CcSEcCtD
Pyridostigmine—Asthenia—Dactinomycin—sarcoma	0.00146	0.00481	CcSEcCtD
Pyridostigmine—Feeling abnormal—Mitoxantrone—sarcoma	0.00146	0.00481	CcSEcCtD
Pyridostigmine—Asthma—Epirubicin—sarcoma	0.00146	0.00479	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00145	0.00477	CcSEcCtD
Pyridostigmine—Abdominal pain—Vincristine—sarcoma	0.00144	0.00474	CcSEcCtD
Pyridostigmine—Dry skin—Doxorubicin—sarcoma	0.00143	0.0047	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Etoposide—sarcoma	0.00143	0.00469	CcSEcCtD
Pyridostigmine—Urticaria—Mitoxantrone—sarcoma	0.00141	0.00464	CcSEcCtD
Pyridostigmine—Diarrhoea—Thiotepa—sarcoma	0.00141	0.00462	CcSEcCtD
Pyridostigmine—Abdominal pain—Mitoxantrone—sarcoma	0.0014	0.00461	CcSEcCtD
Pyridostigmine—Bronchitis—Epirubicin—sarcoma	0.0014	0.0046	CcSEcCtD
Pyridostigmine—Diarrhoea—Dactinomycin—sarcoma	0.0014	0.00459	CcSEcCtD
Pyridostigmine—Hypotension—Etoposide—sarcoma	0.00138	0.00454	CcSEcCtD
Pyridostigmine—Abdominal distension—Doxorubicin—sarcoma	0.00136	0.00446	CcSEcCtD
Pyridostigmine—Asthma—Doxorubicin—sarcoma	0.00135	0.00443	CcSEcCtD
Pyridostigmine—Pollakiuria—Epirubicin—sarcoma	0.00134	0.00442	CcSEcCtD
Pyridostigmine—Hypersensitivity—Vincristine—sarcoma	0.00134	0.00442	CcSEcCtD
Pyridostigmine—Paraesthesia—Etoposide—sarcoma	0.00133	0.00436	CcSEcCtD
Pyridostigmine—Somnolence—Etoposide—sarcoma	0.00131	0.00432	CcSEcCtD
Pyridostigmine—Hypersensitivity—Mitoxantrone—sarcoma	0.00131	0.0043	CcSEcCtD
Pyridostigmine—Asthenia—Vincristine—sarcoma	0.00131	0.0043	CcSEcCtD
Pyridostigmine—Vomiting—Thiotepa—sarcoma	0.00131	0.0043	CcSEcCtD
Pyridostigmine—Drowsiness—Epirubicin—sarcoma	0.0013	0.00427	CcSEcCtD
Pyridostigmine—Vomiting—Dactinomycin—sarcoma	0.0013	0.00427	CcSEcCtD
Pyridostigmine—Rash—Thiotepa—sarcoma	0.0013	0.00426	CcSEcCtD
Pyridostigmine—Bronchitis—Doxorubicin—sarcoma	0.0013	0.00426	CcSEcCtD
Pyridostigmine—Dermatitis—Thiotepa—sarcoma	0.0013	0.00426	CcSEcCtD
Pyridostigmine—Headache—Thiotepa—sarcoma	0.00129	0.00423	CcSEcCtD
Pyridostigmine—Rash—Dactinomycin—sarcoma	0.00129	0.00423	CcSEcCtD
Pyridostigmine—Asthenia—Mitoxantrone—sarcoma	0.00127	0.00419	CcSEcCtD
Pyridostigmine—Diarrhoea—Vincristine—sarcoma	0.00125	0.0041	CcSEcCtD
Pyridostigmine—Pollakiuria—Doxorubicin—sarcoma	0.00124	0.00409	CcSEcCtD
Pyridostigmine—Epistaxis—Epirubicin—sarcoma	0.00122	0.00402	CcSEcCtD
Pyridostigmine—Nausea—Thiotepa—sarcoma	0.00122	0.00401	CcSEcCtD
Pyridostigmine—Feeling abnormal—Etoposide—sarcoma	0.00122	0.004	CcSEcCtD
Pyridostigmine—Diarrhoea—Mitoxantrone—sarcoma	0.00121	0.00399	CcSEcCtD
Pyridostigmine—Nausea—Dactinomycin—sarcoma	0.00121	0.00398	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Etoposide—sarcoma	0.00121	0.00397	CcSEcCtD
Pyridostigmine—Drowsiness—Doxorubicin—sarcoma	0.0012	0.00395	CcSEcCtD
Pyridostigmine—Bradycardia—Epirubicin—sarcoma	0.00119	0.0039	CcSEcCtD
Pyridostigmine—Urticaria—Etoposide—sarcoma	0.00117	0.00386	CcSEcCtD
Pyridostigmine—Abdominal pain—Etoposide—sarcoma	0.00117	0.00384	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Epirubicin—sarcoma	0.00116	0.00381	CcSEcCtD
Pyridostigmine—Vomiting—Vincristine—sarcoma	0.00116	0.00381	CcSEcCtD
Pyridostigmine—Rash—Vincristine—sarcoma	0.00115	0.00378	CcSEcCtD
Pyridostigmine—Dermatitis—Vincristine—sarcoma	0.00115	0.00378	CcSEcCtD
Pyridostigmine—Headache—Vincristine—sarcoma	0.00114	0.00375	CcSEcCtD
Pyridostigmine—Epistaxis—Doxorubicin—sarcoma	0.00113	0.00372	CcSEcCtD
Pyridostigmine—Vomiting—Mitoxantrone—sarcoma	0.00113	0.00371	CcSEcCtD
Pyridostigmine—Rash—Mitoxantrone—sarcoma	0.00112	0.00368	CcSEcCtD
Pyridostigmine—Dermatitis—Mitoxantrone—sarcoma	0.00112	0.00368	CcSEcCtD
Pyridostigmine—Headache—Mitoxantrone—sarcoma	0.00111	0.00366	CcSEcCtD
Pyridostigmine—Bradycardia—Doxorubicin—sarcoma	0.0011	0.00361	CcSEcCtD
Pyridostigmine—Hypersensitivity—Etoposide—sarcoma	0.00109	0.00358	CcSEcCtD
Pyridostigmine—Nausea—Vincristine—sarcoma	0.00108	0.00356	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Doxorubicin—sarcoma	0.00107	0.00353	CcSEcCtD
Pyridostigmine—Asthenia—Etoposide—sarcoma	0.00106	0.00348	CcSEcCtD
Pyridostigmine—Nausea—Mitoxantrone—sarcoma	0.00105	0.00347	CcSEcCtD
Pyridostigmine—Alopecia—Epirubicin—sarcoma	0.00103	0.00338	CcSEcCtD
Pyridostigmine—Diarrhoea—Etoposide—sarcoma	0.00101	0.00332	CcSEcCtD
Pyridostigmine—Flatulence—Epirubicin—sarcoma	0.001	0.00329	CcSEcCtD
Pyridostigmine—Muscle spasms—Epirubicin—sarcoma	0.000975	0.00321	CcSEcCtD
Pyridostigmine—Alopecia—Doxorubicin—sarcoma	0.000953	0.00313	CcSEcCtD
Pyridostigmine—Vomiting—Etoposide—sarcoma	0.000939	0.00309	CcSEcCtD
Pyridostigmine—Agitation—Epirubicin—sarcoma	0.000932	0.00306	CcSEcCtD
Pyridostigmine—Rash—Etoposide—sarcoma	0.000931	0.00306	CcSEcCtD
Pyridostigmine—Dermatitis—Etoposide—sarcoma	0.00093	0.00306	CcSEcCtD
Pyridostigmine—Headache—Etoposide—sarcoma	0.000925	0.00304	CcSEcCtD
Pyridostigmine—Flatulence—Doxorubicin—sarcoma	0.000925	0.00304	CcSEcCtD
Pyridostigmine—Vertigo—Epirubicin—sarcoma	0.000911	0.003	CcSEcCtD
Pyridostigmine—Muscle spasms—Doxorubicin—sarcoma	0.000902	0.00297	CcSEcCtD
Pyridostigmine—Loss of consciousness—Epirubicin—sarcoma	0.000892	0.00293	CcSEcCtD
Pyridostigmine—Convulsion—Epirubicin—sarcoma	0.000879	0.00289	CcSEcCtD
Pyridostigmine—Nausea—Etoposide—sarcoma	0.000877	0.00288	CcSEcCtD
Pyridostigmine—Myalgia—Epirubicin—sarcoma	0.000864	0.00284	CcSEcCtD
Pyridostigmine—Agitation—Doxorubicin—sarcoma	0.000863	0.00284	CcSEcCtD
Pyridostigmine—Vertigo—Doxorubicin—sarcoma	0.000843	0.00277	CcSEcCtD
Pyridostigmine—Confusional state—Epirubicin—sarcoma	0.000835	0.00274	CcSEcCtD
Pyridostigmine—Loss of consciousness—Doxorubicin—sarcoma	0.000825	0.00271	CcSEcCtD
Pyridostigmine—Convulsion—Doxorubicin—sarcoma	0.000813	0.00267	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Epirubicin—sarcoma	0.0008	0.00263	CcSEcCtD
Pyridostigmine—Myalgia—Doxorubicin—sarcoma	0.000799	0.00263	CcSEcCtD
Pyridostigmine—Hypotension—Epirubicin—sarcoma	0.000774	0.00254	CcSEcCtD
Pyridostigmine—Confusional state—Doxorubicin—sarcoma	0.000772	0.00254	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000754	0.00248	CcSEcCtD
Pyridostigmine—Paraesthesia—Epirubicin—sarcoma	0.000743	0.00244	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Doxorubicin—sarcoma	0.000741	0.00243	CcSEcCtD
Pyridostigmine—Somnolence—Epirubicin—sarcoma	0.000736	0.00242	CcSEcCtD
Pyridostigmine—Hypotension—Doxorubicin—sarcoma	0.000716	0.00235	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000698	0.00229	CcSEcCtD
Pyridostigmine—Paraesthesia—Doxorubicin—sarcoma	0.000688	0.00226	CcSEcCtD
Pyridostigmine—Feeling abnormal—Epirubicin—sarcoma	0.000682	0.00224	CcSEcCtD
Pyridostigmine—Somnolence—Doxorubicin—sarcoma	0.000681	0.00224	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Epirubicin—sarcoma	0.000677	0.00223	CcSEcCtD
Pyridostigmine—Urticaria—Epirubicin—sarcoma	0.000658	0.00216	CcSEcCtD
Pyridostigmine—Abdominal pain—Epirubicin—sarcoma	0.000654	0.00215	CcSEcCtD
Pyridostigmine—Feeling abnormal—Doxorubicin—sarcoma	0.000631	0.00208	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Doxorubicin—sarcoma	0.000626	0.00206	CcSEcCtD
Pyridostigmine—Hypersensitivity—Epirubicin—sarcoma	0.00061	0.00201	CcSEcCtD
Pyridostigmine—Urticaria—Doxorubicin—sarcoma	0.000609	0.002	CcSEcCtD
Pyridostigmine—Abdominal pain—Doxorubicin—sarcoma	0.000606	0.00199	CcSEcCtD
Pyridostigmine—Asthenia—Epirubicin—sarcoma	0.000594	0.00195	CcSEcCtD
Pyridostigmine—Diarrhoea—Epirubicin—sarcoma	0.000566	0.00186	CcSEcCtD
Pyridostigmine—Hypersensitivity—Doxorubicin—sarcoma	0.000564	0.00186	CcSEcCtD
Pyridostigmine—Asthenia—Doxorubicin—sarcoma	0.00055	0.00181	CcSEcCtD
Pyridostigmine—Vomiting—Epirubicin—sarcoma	0.000526	0.00173	CcSEcCtD
Pyridostigmine—Diarrhoea—Doxorubicin—sarcoma	0.000524	0.00172	CcSEcCtD
Pyridostigmine—Rash—Epirubicin—sarcoma	0.000522	0.00172	CcSEcCtD
Pyridostigmine—Dermatitis—Epirubicin—sarcoma	0.000522	0.00171	CcSEcCtD
Pyridostigmine—Headache—Epirubicin—sarcoma	0.000519	0.0017	CcSEcCtD
Pyridostigmine—Nausea—Epirubicin—sarcoma	0.000492	0.00162	CcSEcCtD
Pyridostigmine—Vomiting—Doxorubicin—sarcoma	0.000487	0.0016	CcSEcCtD
Pyridostigmine—Rash—Doxorubicin—sarcoma	0.000483	0.00159	CcSEcCtD
Pyridostigmine—Dermatitis—Doxorubicin—sarcoma	0.000483	0.00159	CcSEcCtD
Pyridostigmine—Headache—Doxorubicin—sarcoma	0.00048	0.00158	CcSEcCtD
Pyridostigmine—Nausea—Doxorubicin—sarcoma	0.000455	0.0015	CcSEcCtD
